Cargando…
Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis
BACKGROUND: Conventional meta-analyses and randomized controlled trials have shown inconsistent results regarding the efficacy of immunosuppressants for pediatric steroid-resistant nephrotic syndrome (SRNS). OBJECTIVE: To conduct a network meta-analysis aimed at evaluating the efficacy and safety of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641191/ https://www.ncbi.nlm.nih.gov/pubmed/29069848 http://dx.doi.org/10.18632/oncotarget.20377 |
_version_ | 1783271180945326080 |
---|---|
author | Li, Shaojun Yang, Haiping Guo, Pengfei Ao, Xiaoxiao Wan, Junli Li, Qiu Tan, Liping |
author_facet | Li, Shaojun Yang, Haiping Guo, Pengfei Ao, Xiaoxiao Wan, Junli Li, Qiu Tan, Liping |
author_sort | Li, Shaojun |
collection | PubMed |
description | BACKGROUND: Conventional meta-analyses and randomized controlled trials have shown inconsistent results regarding the efficacy of immunosuppressants for pediatric steroid-resistant nephrotic syndrome (SRNS). OBJECTIVE: To conduct a network meta-analysis aimed at evaluating the efficacy and safety of available immunosuppressive agents in pediatric patients with SRNS. STUDY METHODS: MEDLINE, the Cochrane Central Register of Controlled Trials, and EMBASE were searched on January 2017. Data from randomized controlled trials (RCTs) were included. The main outcomes analyzed were efficacy [number/portion with complete remission (CR), number/portion with partial remission (PR), and total number/portion in remission (TR)] and safety [adverse secondary event (ASE) rates]. RESULTS: A meta-analysis of 18 RCTs showed that tacrolimus was more efficacious for achieving CR than intravenous (i.v.) cyclophosphamide, mycophenolate mofetil (MMF), oral cyclophosphamide, leflunomide, chlorambucil, azathioprine, and plaebo/nontreatment (P/NT), and more efficacious than i.v. cyclophosphamide, oral cyclophosphamide, and P/NT in terms of TR outcomes. Cyclosporin was associated with a greater CR rate than i.v. cyclophosphamide, MMF, oral cyclophosphamide, chlorambucil, azathioprine, or P/NT, and associated with a greater TR rate than i.v. cyclophosphamide, oral cyclophosphamide, or P/NT. MMF was found to be more efficacious than i.v. cyclophosphamide and oral cyclophosphamide in terms of TR. CONCLUSIONS: Tacrolimus and cyclosporine may be preferred initial treatments for children with SRNS. MMF may be another option for this patient population. Further studies of the efficacy and safety of these three drugs in children with SRNS should be pursued. |
format | Online Article Text |
id | pubmed-5641191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56411912017-10-24 Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis Li, Shaojun Yang, Haiping Guo, Pengfei Ao, Xiaoxiao Wan, Junli Li, Qiu Tan, Liping Oncotarget Meta-Analysis BACKGROUND: Conventional meta-analyses and randomized controlled trials have shown inconsistent results regarding the efficacy of immunosuppressants for pediatric steroid-resistant nephrotic syndrome (SRNS). OBJECTIVE: To conduct a network meta-analysis aimed at evaluating the efficacy and safety of available immunosuppressive agents in pediatric patients with SRNS. STUDY METHODS: MEDLINE, the Cochrane Central Register of Controlled Trials, and EMBASE were searched on January 2017. Data from randomized controlled trials (RCTs) were included. The main outcomes analyzed were efficacy [number/portion with complete remission (CR), number/portion with partial remission (PR), and total number/portion in remission (TR)] and safety [adverse secondary event (ASE) rates]. RESULTS: A meta-analysis of 18 RCTs showed that tacrolimus was more efficacious for achieving CR than intravenous (i.v.) cyclophosphamide, mycophenolate mofetil (MMF), oral cyclophosphamide, leflunomide, chlorambucil, azathioprine, and plaebo/nontreatment (P/NT), and more efficacious than i.v. cyclophosphamide, oral cyclophosphamide, and P/NT in terms of TR outcomes. Cyclosporin was associated with a greater CR rate than i.v. cyclophosphamide, MMF, oral cyclophosphamide, chlorambucil, azathioprine, or P/NT, and associated with a greater TR rate than i.v. cyclophosphamide, oral cyclophosphamide, or P/NT. MMF was found to be more efficacious than i.v. cyclophosphamide and oral cyclophosphamide in terms of TR. CONCLUSIONS: Tacrolimus and cyclosporine may be preferred initial treatments for children with SRNS. MMF may be another option for this patient population. Further studies of the efficacy and safety of these three drugs in children with SRNS should be pursued. Impact Journals LLC 2017-08-21 /pmc/articles/PMC5641191/ /pubmed/29069848 http://dx.doi.org/10.18632/oncotarget.20377 Text en Copyright: © 2017 Li et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Meta-Analysis Li, Shaojun Yang, Haiping Guo, Pengfei Ao, Xiaoxiao Wan, Junli Li, Qiu Tan, Liping Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis |
title | Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis |
title_full | Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis |
title_fullStr | Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis |
title_full_unstemmed | Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis |
title_short | Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis |
title_sort | efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis |
topic | Meta-Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641191/ https://www.ncbi.nlm.nih.gov/pubmed/29069848 http://dx.doi.org/10.18632/oncotarget.20377 |
work_keys_str_mv | AT lishaojun efficacyandsafetyofimmunosuppressivemedicationsforsteroidresistantnephroticsyndromeinchildrenasystematicreviewandnetworkmetaanalysis AT yanghaiping efficacyandsafetyofimmunosuppressivemedicationsforsteroidresistantnephroticsyndromeinchildrenasystematicreviewandnetworkmetaanalysis AT guopengfei efficacyandsafetyofimmunosuppressivemedicationsforsteroidresistantnephroticsyndromeinchildrenasystematicreviewandnetworkmetaanalysis AT aoxiaoxiao efficacyandsafetyofimmunosuppressivemedicationsforsteroidresistantnephroticsyndromeinchildrenasystematicreviewandnetworkmetaanalysis AT wanjunli efficacyandsafetyofimmunosuppressivemedicationsforsteroidresistantnephroticsyndromeinchildrenasystematicreviewandnetworkmetaanalysis AT liqiu efficacyandsafetyofimmunosuppressivemedicationsforsteroidresistantnephroticsyndromeinchildrenasystematicreviewandnetworkmetaanalysis AT tanliping efficacyandsafetyofimmunosuppressivemedicationsforsteroidresistantnephroticsyndromeinchildrenasystematicreviewandnetworkmetaanalysis |